HYUNDAI PHARMACEUTICAL CO., LTD — Investor Relations & Filings
HYUNDAI PHARMACEUTICAL CO., LTD. is a company engaged in the research, development, manufacturing, and distribution of pharmaceutical products, medical devices, and health-focused food and beverages. The company's portfolio encompasses a broad range of prescription (ETC) and over-the-counter (OTC) medicines. Key therapeutic areas include dermatology, respiratory and gastrointestinal disorders, as well as treatments for conditions such as hypertension and dementia. With a strong commitment to innovation, the company focuses on the research of new substances and the continuous development of its drug pipeline. It also serves as a strategic partner for global companies, facilitating market entry and collaboration through its business development initiatives.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주요사항보고서(자기주식취득신탁계약해지결정) | 2024-07-12 | Korean | |
| 신탁계약해지결과보고서 | 2024-07-12 | Korean | |
| 반기보고서 (2024.05) | 2024-07-12 | Korean | |
| 투자판단관련주요경영사항 | 2024-05-21 | Korean | |
| 분기보고서 (2024.02) | 2024-04-15 | Korean | |
| 정기주주총회결과 | 2024-02-29 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 8110120 | 주요사항보고서(자기주식취득신탁계약해지결정) | 2024-07-12 | Korean | ||
| 8110118 | 신탁계약해지결과보고서 | 2024-07-12 | Korean | ||
| 8109838 | 반기보고서 (2024.05) | 2024-07-12 | Korean | ||
| 8135075 | 투자판단관련주요경영사항 | 2024-05-21 | Korean | ||
| 8148010 | 분기보고서 (2024.02) | 2024-04-15 | Korean | ||
| 8202182 | 정기주주총회결과 | 2024-02-29 | Korean | ||
| 8202157 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2024-02-29 | Korean | ||
| 8209734 | 감사보고서제출 | 2024-02-21 | Korean | ||
| 8209588 | 사업보고서 (2023.11) | 2024-02-21 | Korean | ||
| 8215478 | 공정거래자율준수프로그램운영현황(안내공시) | 2024-02-13 | Korean | ||
| 8215423 | 주주총회소집결의 | 2024-02-13 | Korean | ||
| 8215397 | 주주총회소집공고 | 2024-02-13 | Korean | ||
| 8215376 | 현금ㆍ현물배당결정 | 2024-02-13 | Korean | ||
| 8215367 | 현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정 | 2024-02-13 | Korean | ||
| 8215232 | [기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경 | 2024-02-13 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
HYUNDAI PHARMACEUTICAL CO., LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17134/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17134 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17134 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17134 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17134}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HYUNDAI PHARMACEUTICAL CO., LTD (id: 17134)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.